Seminars in Immunopathology

(The TQCC of Seminars in Immunopathology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
The interplay between immunosenescence and age-related diseases160
Preterm birth and sustained inflammation: consequences for the neonate135
Control of immunity by glucocorticoids in health and disease99
Pathogenesis of preterm birth: bidirectional inflammation in mother and fetus92
Adrenergic regulation of immune cell function and inflammation92
The pregnancy microbiome and preterm birth79
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome75
Genetics of rheumatoid arthritis74
Tipping the balance: intricate roles of the complement system in disease and therapy69
Microbiomes other than the gut: inflammaging and age-related diseases67
TNF in the liver: targeting a central player in inflammation66
Inflammatory Responses After Ischemic Stroke64
IgA vasculitis63
Mitochondria, immunosenescence and inflammaging: a role for mitokines?62
Immunosenescence is both functional/adaptive and dysfunctional/maladaptive62
Current treatment of IgA nephropathy60
The mucosal immune system and IgA nephropathy60
The untwining of immunosenescence and aging59
Novel pathways of inflammation in human fetal membranes associated with preterm birth and preterm pre-labor rupture of the membranes53
Thymus and autoimmunity51
Role of bile acids in inflammatory liver diseases48
Complement activation in IgA nephropathy48
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation47
Brain aging and garbage cleaning43
Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies41
Circadian rhythms in adaptive immunity and vaccination41
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population39
The immunology of Parkinson’s disease38
IgA glycosylation and immune complex formation in IgAN37
Down syndrome, accelerated aging and immunosenescence36
Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies36
Recent advances in understanding the genetic basis of systemic lupus erythematosus32
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity32
Adipose tissue, immune aging, and cellular senescence31
Adaptive immunity, chronic inflammation and the clock31
The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights30
Dynamics of thymus function and T cell receptor repertoire breadth in health and disease30
Is IgA nephropathy the same disease in different parts of the world?29
Tumor microenvironment antigens27
Eosinophils in skin diseases27
Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis26
Eosinophilic esophagitis—established facts and new horizons26
What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?26
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts25
Eosinophils and helminth infection: protective or pathogenic?25
The aryl hydrocarbon receptor in liver inflammation24
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease24
Novel immune cell phenotypes in spondyloarthritis pathogenesis24
Age as a risk factor in vasculitis24
Light at night disrupts biological clocks, calendars, and immune function23
The complex relationship between Immunosenescence and Inflammaging: Special issue on the New Biomedical Perspectives23
Intestinal eosinophils, homeostasis and response to bacterial intrusion23
HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases23